Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
What is value investing? Discover the principles behind this strategy and how it can enhance your investment approach.
19,897 articlesAmgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A quiet strategic shift could power ELF's growth without fanfare. This article breaks down what the move is, why it m...
A private equity veteran, famed for saving Arby’s, now champions a $2.7 billion bid for Pizza Hut. The deal splits be...
SpaceX has pulled back from its recent peak, dropping around 18%. This article explains why this move isn’t a reason ...
In volatile markets, pulling back can create buying opportunities. This article highlights three growth stocks to buy...
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Netflix has chased big bets beyond subscribers, but the road from ambition to profits is rocky. This article breaks d...
Sprinklr has seen a steep slide, slipping about 40% over the past year. A large fund recently sold close to $3 millio...
Lilly shares moved lower after Novo Nordisk announced price cuts on leading obesity drugs, signaling a tougher compet...
MercadoLibre's fourth-quarter results showed strong revenue growth, but a notable drop in profitability. This article...
Silver miners often move with the metal itself. Here's shares Hecla Mining climbed as silver trades fluctuated, but s...
Kraft Heinz pauses its planned breakup after a string of profit slips and a Berkshire Hathaway stake-shift. The move ...